DCE Journal Review March 2018

DCE Journal Review March 2018


  1. A Plant-Based Dietary Intervention Improves Beta-Cell Function and Insulin Resistance in Overweight Adults: A 16-Week Randomized Clinical Trial.
  2. Risk of Cardiovascular Disease and Death in Individuals With Prediabetes Defined by Different Criteria: The Whitehall II Study.

Type I Diabetes:

  1.  Hypoglycemia unawareness in type 1 diabetes suppresses brain responses to hypoglycemia

Type II Diabetes:

  1. Cardiovascular Safety, Long‐Term Noncardiovascular Safety, and Efficacy of Sodium–Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes Mellitus: A Systemic Review and Meta‐Analysis With Trial Sequential Analysis.
  2. Elevations of metabolic risk factors 20 years or more before diagnosis of type 2 diabetes – experience from the AMORIS study.
  3. Comparative Safety of Sulfonylureas and the Risk of Sudden Cardiac Arrest and Ventricular Arrhythmia.
  4. Precision Medicine in Type 2 Diabetes: Clinical Markers of Insulin Resistance Are Associated With Altered Short- and Long-Term Glycemic Response to DPP-4 Inhibitor Therapy
  5. Night Shift Work, Genetic Risk, and Type 2 Diabetes in the UK Biobank
  6. Retinol-binding protein 4 is positively associated with bone mineral density in osteopenia and osteoporosis type 2 diabetic patients.
  7. Impact of Abdominal Subcutaneous Fat Reduction on Glycemic Control in Obese Patients with Type 2 Diabetes Mellitus.

Pediatric Diabetes:

  1. Dietary approach to stop hypertension diet and cardiovascular risk factors among 10- to 18-year-old individuals.
  2. Food Insecurity is Associated with High Risk Glycemic Control and Higher Health Care Utilization among Youth and Young Adults with Type 1 Diabetes.

Gestational Diabetes:

  1. Is dietary macronutrient composition during pregnancy associated with offspring birth weight? An observational study

Metabolic Syndrome:

  1. The Impact of Intragastric Balloons on Obesity-Related Co-Morbidities: A Systematic Review and Meta-Analysis.

Diabetes Management:

  1. A Prospective Multicenter Evaluation of the Accuracy of a Novel Implanted Continuous Glucose Sensor: PRECISE II.
  2. Metformin Treatment in Patients With Type 2 Diabetes and Chronic Kidney Disease Stages 3A, 3B, or 4.

Monthly Journal Review Archive